ArticleCells2022

Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study.

Federico Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.